Sign in
4

Changes in Ownership

SELLAS Life Sciences Group, Inc. Filed Acc 0001390478-14-000030

VP, Chief Financial Officer acquired 2,461 shares (other)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Dunlap Ryan VP, Chief Financial Officer 2014-06-30 Other acquisition +2,461 $2.60 $6,399 7,804 D: show line 1 in the form
Loading xslF345X03/primary_doc.xml…